for the year ended September 30, 2025
|
EUR 000 |
2024/2025 |
2023/2024 |
|
|
Profit for the year |
– |
– |
|
|
Adjustments for: |
|||
|
Income tax expense |
1,369 |
2,238 |
|
|
Impairment trade receivables and contract assets |
580 |
1,401 |
|
|
Depreciation and amortization |
37,834 |
38,424 |
|
|
Impairment losses on property, plant and equipment |
517 |
– |
|
|
Finance income |
-1,076 |
-2,099 |
|
|
Finance expenses |
11,295 |
9,339 |
|
|
Cash flows before movements in working capital and provisions |
50,519 |
49,303 |
|
|
Change in contract assets |
-1,777 |
-6,515 |
|
|
Change in trade and other receivables |
780 |
-5,643 |
|
|
Change in other assets |
433 |
408 |
|
|
Change in contract liabilities |
4,421 |
468 |
|
|
Change in trade and other payables |
-3,284 |
11,325 |
|
|
Change in provisions |
2,334 |
-40,106 |
|
|
Change in employee benefits |
2,467 |
10,165 |
|
|
Cash flows from operating activities |
55,893 |
19,405 |
|
|
Income tax paid |
-1,884 |
-1,934 |
|
|
Net cash from operating activities |
54,009 |
17,471 |
|
|
Acquisition of property, plant and equipment |
-10,683 |
-3,730 |
|
|
Investment in software |
-1,042 |
-1,256 |
|
|
Net cash used in investing activities |
-11,725 |
-4,986 |
|
|
Additional share premium paid by Coöperatie KPMG U.A. |
2,550 |
2,460 |
|
|
Net proceeds of loans and borrowings from partners |
15,546 |
30,008 |
|
|
Net proceeds of loans and borrowings from former partners |
409 |
1,316 |
|
|
Interest paid to Coöperatie KPMG U.A. re partners and former partners |
-5,398 |
-5,454 |
|
|
Repayment of share premium to Coöperatie KPMG U.A. |
-2,250 |
-990 |
|
|
Interest and bank charges paid |
-6,192 |
-4,170 |
|
|
Interest received |
1,076 |
2,099 |
|
|
Payment of lease liabilities |
-29,720 |
-31,187 |
|
|
Proceeds of employee bonds |
1,990 |
1,517 |
|
|
Repayment of employee bonds |
-964 |
-1,661 |
|
|
Net cash used in financing activities |
-22,953 |
-6,062 |
|
|
Net change in cash and cash equivalents |
19,331 |
6,423 |
|
|
Cash and cash equivalents as at October 1 |
142,577 |
136,154 |
|
|
Cash and cash equivalents as at September 30 |
161,908 |
142,577 |
The accompanying notes are an integral part of these consolidated financial statements.